Broadly neutralizing antibodies found in the blood of Ebola survivors: Study
by Press Release from Outbreak News Today on (#3V2VJ)
Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly disease. ZMapp, an experimental therapy comprising three monoclonal antibodies, has shown promise in a clinical trial, but it targets only one ["]
The post Broadly neutralizing antibodies found in the blood of Ebola survivors: Study appeared first on Outbreak News Today.